These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

651 related items for PubMed ID: 22932262

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Phase II study of concurrent chemoradiotherapy with high-dose-rate intracavitary brachytherapy in patients with locally advanced uterine cervical cancer: efficacy and toxicity of a low cumulative radiation dose schedule.
    Toita T, Kitagawa R, Hamano T, Umayahara K, Hirashima Y, Aoki Y, Oguchi M, Mikami M, Takizawa K, Cervical Cancer (Vulva Cancer) Committee of Japanese Gynecologic Oncology Group (JGOG).
    Gynecol Oncol; 2012 Aug; 126(2):211-6. PubMed ID: 22555110
    [Abstract] [Full Text] [Related]

  • 3. Impact of Treatment Time on Chemoradiotherapy in Locally Advanced Cervical Carcinoma.
    Pathy S, Kumar L, Pandey RM, Upadhyay A, Roy S, Dadhwal V, Madan R, Chander S.
    Asian Pac J Cancer Prev; 2015 Aug; 16(12):5075-9. PubMed ID: 26163644
    [Abstract] [Full Text] [Related]

  • 4. Role of Surgical Versus Clinical Staging in Chemoradiated FIGO Stage IIB-IVA Cervical Cancer Patients-Acute Toxicity and Treatment Quality of the Uterus-11 Multicenter Phase III Intergroup Trial of the German Radiation Oncology Group and the Gynecologic Cancer Group.
    Marnitz S, Martus P, Köhler C, Stromberger C, Asse E, Mallmann P, Schmidberger H, Affonso Júnior RJ, Nunes JS, Sehouli J, Budach V.
    Int J Radiat Oncol Biol Phys; 2016 Feb 01; 94(2):243-53. PubMed ID: 26853333
    [Abstract] [Full Text] [Related]

  • 5. A phase II study of bevacizumab in combination with definitive radiotherapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma: preliminary results of RTOG 0417.
    Schefter TE, Winter K, Kwon JS, Stuhr K, Balaraj K, Yaremko BP, Small W, Gaffney DK.
    Int J Radiat Oncol Biol Phys; 2012 Jul 15; 83(4):1179-84. PubMed ID: 22342094
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Daily low-dose Cisplatin-based concurrent chemoradiotherapy for the treatment of cervical cancer in patients 70 years or older.
    Hanawa S, Mitsuhashi A, Usui H, Yamamoto N, Watanabe-Nemoto M, Nishikimi K, Uehara T, Tate S, Uno T, Shozu M.
    Int J Gynecol Cancer; 2015 Jun 15; 25(5):891-6. PubMed ID: 25811592
    [Abstract] [Full Text] [Related]

  • 8. Concurrent chemoradiotherapy using high-dose-rate intracavitary brachytherapy for uterine cervical cancer.
    Toita T, Moromizato H, Ogawa K, Kakinohana Y, Maehama T, Kanazawa K, Murayama S.
    Gynecol Oncol; 2005 Mar 15; 96(3):665-70. PubMed ID: 15721409
    [Abstract] [Full Text] [Related]

  • 9. Helical tomotherapy with simultaneous integrated boost after laparoscopic staging in patients with cervical cancer: analysis of feasibility and early toxicity.
    Marnitz S, Köhler C, Burova E, Wlodarczyk W, Jahn U, Grün A, Budach V, Stromberger C.
    Int J Radiat Oncol Biol Phys; 2012 Feb 01; 82(2):e137-43. PubMed ID: 21600704
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Toxicity of concurrent chemoradiotherapy for locally advanced cervical cancer.
    Jakubowicz J, Blecharz P, Skotnicki P, Reinfuss M, Walasek T, Luczynska E.
    Eur J Gynaecol Oncol; 2014 Feb 01; 35(4):393-9. PubMed ID: 25118480
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Twice-daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aortic lymph nodes: Phase II study of the Radiation Therapy Oncology Group 92-10.
    Grigsby PW, Lu JD, Mutch DG, Kim RY, Eifel PJ.
    Int J Radiat Oncol Biol Phys; 1998 Jul 01; 41(4):817-22. PubMed ID: 9652843
    [Abstract] [Full Text] [Related]

  • 16. RTOG 0417: efficacy of bevacizumab in combination with definitive radiation therapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma.
    Schefter T, Winter K, Kwon JS, Stuhr K, Balaraj K, Yaremko BP, Small W, Sause W, Gaffney D, Radiation Therapy Oncology Group (RTOG).
    Int J Radiat Oncol Biol Phys; 2014 Jan 01; 88(1):101-5. PubMed ID: 24331655
    [Abstract] [Full Text] [Related]

  • 17. Chemoradiation in cervical cancer with cisplatin and high-dose rate brachytherapy combined with external beam radiotherapy. Results of a phase-II study.
    Strauss HG, Kuhnt T, Laban C, Puschmann D, Pigorsch S, Dunst J, Koelbl H, Haensgen G.
    Strahlenther Onkol; 2002 Jul 01; 178(7):378-85. PubMed ID: 12163992
    [Abstract] [Full Text] [Related]

  • 18. Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (<4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2).
    Toita T, Kato S, Niibe Y, Ohno T, Kazumoto T, Kodaira T, Kataoka M, Shikama N, Kenjo M, Tokumaru S, Yamauchi C, Suzuki O, Sakurai H, Numasaki H, Teshima T, Oguchi M, Kagami Y, Nakano T, Hiraoka M, Mitsuhashi N.
    Int J Radiat Oncol Biol Phys; 2012 Jan 01; 82(1):e49-56. PubMed ID: 21470794
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Phase II study of concurrent chemoradiotherapy with weekly cisplatin and paclitaxel in patients with locally advanced uterine cervical cancer: The JACCRO GY-01 trial.
    Umayahara K, Takekuma M, Hirashima Y, Noda SE, Ohno T, Miyagi E, Hirahara F, Hirata E, Kondo E, Tabata T, Nagai Y, Aoki Y, Wakatsuki M, Takeuchi M, Toita T, Takeshima N, Takizawa K.
    Gynecol Oncol; 2016 Feb 01; 140(2):253-8. PubMed ID: 26701414
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.